In a bind? Comprehend releases risk detection and management platform for mid-sized CROs

By Maggie Lynch contact

- Last updated on GMT

(Image: Getty/William_Potter)
(Image: Getty/William_Potter)

Related tags: Risk, risk assessment, Data management, CRO, Clinical data, analytics

Comprehend, a clinical intelligence software company, has packaged its clinical trial risk detection and management service offerings to accommodate the needs of mid-sized CROs.

The company’s Clinical Intelligence Platform (CIP) is aimed at supporting contract research organization’s (CROs) needs through analytics and continuous data aggregation. The platform also allows for CROs to adhere to ICH E6(R2)​, a guideline for good clinical practice.

 Rick Morrison president and founder of Comprehend told us that the company’s newest offering is aimed at the needs of mid-sized CROs, which have been expected to provide an increasing amount of services.

Research has shown that there are about 6.5 data collection systems per study, making the margin of error and risk harder to manage during data analysis, explained Morrison

However, while larger CROs have invested in technology to simplify the increasing demands, mid-sized CROs are “in a bind,”​ he said.

To address this, Comprehend’s new offering includes a set of analytics and data monitoring that integrates with the CRO’s risk management programs for sponsors.

Morrison told us, “Our clinical intelligence platform is our core technology and solution. It is what brings the data together from the various systems that exist. It brings the data together, integrates it, digests it, and harmonizes it to make sure it works together on a unified study data model.”

Related news

Show more

Related products

show more

What do big pharma companies spend on R&D?

What do big pharma companies spend on R&D?

Zymewire | 15-Aug-2019 | Technical / White Paper

The free Big Pharma R&D Spend report examines the financial performance and research & development investments of the top 25 pharmaceutical companies...

Stability Testing As a Quality Control Measure

Stability Testing As a Quality Control Measure

Frontage Laboratories | 19-Jun-2019 | Technical / White Paper

Stability testing is, in essence, a quality control process and is there¬fore a vital component of every phase of clinical development for both large and...

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 05-Nov-2018 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

Related suppliers

Follow us

Products

View more

Webinars